ResearcherNational Institutes of HealthActive in the last 2 years
Yasunori Otowa
Matched on ORCID iD 0000-0001-8421-7343; OpenAlex author ID A5023146293. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 3
- Pharmacologic ascorbate induces transient hypoxia sensitizing pancreatic ductal adenocarcinoma to a hypoxia activated prodrug. Co-author DOI 10.1016/j.freeradbiomed.2024.07.008↗
- Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature and Inhibition of Homologous Recombination… Co-author DOI 10.1089/ars.2022.0118↗
- PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study. Co-author DOI 10.1016/j.neo.2022.100793↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jeffrey Brender · 3 shared papers, 2022–2024 · strength 0.54
- Paper Pharmacologic ascorbate induces transient hypoxia sensitizing pancreatic ductal adenocarcinoma to a hypoxia activated p… DOI 10.1016/j.freeradbiomed.2024.07.008↗
- Paper Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature an… DOI 10.1089/ars.2022.0118↗
- Paper PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. … DOI 10.1016/j.neo.2022.100793↗
- Kazutoshi Yamamoto · 3 shared papers, 2022–2024 · strength 0.54
- Paper Pharmacologic ascorbate induces transient hypoxia sensitizing pancreatic ductal adenocarcinoma to a hypoxia activated p… DOI 10.1016/j.freeradbiomed.2024.07.008↗
- Paper Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature an… DOI 10.1089/ars.2022.0118↗
- Paper PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. … DOI 10.1016/j.neo.2022.100793↗
- Shun Kishimoto · 3 shared papers, 2022–2024 · strength 0.54
- Paper Pharmacologic ascorbate induces transient hypoxia sensitizing pancreatic ductal adenocarcinoma to a hypoxia activated p… DOI 10.1016/j.freeradbiomed.2024.07.008↗
- Paper Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature an… DOI 10.1089/ars.2022.0118↗
- Paper PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. … DOI 10.1016/j.neo.2022.100793↗
- Murali Cherukuri Krishna · 3 shared papers, 2022–2024 · strength 0.54
- Paper Pharmacologic ascorbate induces transient hypoxia sensitizing pancreatic ductal adenocarcinoma to a hypoxia activated p… DOI 10.1016/j.freeradbiomed.2024.07.008↗
- Paper Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature an… DOI 10.1089/ars.2022.0118↗
- Paper PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. … DOI 10.1016/j.neo.2022.100793↗
- James B. Mitchell · 2 shared papers, 2022–2023 · strength 0.32
- Paper Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature an… DOI 10.1089/ars.2022.0118↗
- Paper PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. … DOI 10.1016/j.neo.2022.100793↗
- William Marston Linehan · 1 shared paper, 2024 · strength 0.22
- Daniel R. Crooks · 1 shared paper, 2024 · strength 0.22
- Mark N. Levine · 1 shared paper, 2024 · strength 0.22
- Tomohiro Seki · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.